← Back to Search

Cognitive Behavioral Therapy + Mindfulness for Alcoholism (ABQTREAT Trial)

N/A
Waitlist Available
Led By Barbara McCrady, PhD
Research Sponsored by University of New Mexico
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Age 22-85 years
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 4-week within treatment visit, 8-week within treatment visit, and 3-month follow-up, 9-month follow-up, and 15-month follow-up
Awards & highlights

ABQTREAT Trial Summary

This trial will help researchers understand how changes in brain function relate to someone reducing their alcohol use.

Who is the study for?
This trial is for individuals aged 22-85 who have been drinking alcohol in the past month and score high on an alcohol use assessment. They must be right-handed, seeking help for their drinking, not currently pregnant or using drugs other than marijuana, and without major health issues like psychosis, low IQ, or brain injuries.Check my eligibility
What is being tested?
The study tests how Cognitive Behavior Therapy (CBT) and Mindfulness-Based Relapse Prevention (MBRP) affect brain function and behavior in people with Alcohol Use Disorder. Participants will undergo therapy sessions over 12 weeks with assessments before and after treatment to track changes.See study design
What are the potential side effects?
While this trial focuses on psychological treatments rather than medication, participants may experience emotional discomfort as they confront their alcohol use patterns during therapy sessions.

ABQTREAT Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 22 and 85 years old.

ABQTREAT Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 4-week within treatment visit, 8-week within treatment visit, and 3-month follow-up, 9-month follow-up, and 15-month follow-up
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 4-week within treatment visit, 8-week within treatment visit, and 3-month follow-up, 9-month follow-up, and 15-month follow-up for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
MOBC: Cognitive and Behavioral Control - behavior
MOBC: Cognitive and Behavioral Control - neuroimaging errors
MOBC: Cognitive and Behavioral Control - neuroimaging inhibition
+5 more
Secondary outcome measures
Drinks per drinking day
Percent drinking days
Percent heavy drinking days

ABQTREAT Trial Design

2Treatment groups
Active Control
Group I: Cognitive-Behavior TherapyActive Control1 Intervention
The CBT condition will include 8 weekly, 60-minute sessions, and will be delivered according to the Epstein & McCrady (2009) cognitive-behavioral treatment manual, excluding material provided in the platform treatment. The treatment manual and accompanying client workbook provide detailed therapist instructions for each session, client exercises, worksheets, and homework assignments. The treatment focuses on cognitive and behavioral coping skills training, and emphasizes problem-solving as an overall approach to dealing with drinking.
Group II: Mindfulness Based Relapse PreventionActive Control1 Intervention
The MBT condition will be adapted from the 8-week version of the mindfulness-based relapse prevention (MBRP) manual (Bowen et al., 2011; Witkiewitz et al., 2005). The main adaptation will be to eliminate the relapse prevention/CBT components and focus attention on mindfulness practices. The mindfulness practices in MBT are designed to increase awareness of triggers and decrease reactivity to distress or discomfort in the presence of triggers (Witkiewitz & Bowen, 2010). The relevant worksheets and homework assignments focusing on mindfulness tools will be maintained from the MBRP manual.

Find a Location

Who is running the clinical trial?

University of New MexicoLead Sponsor
372 Previous Clinical Trials
3,528,649 Total Patients Enrolled
15 Trials studying Alcoholism
2,616 Patients Enrolled for Alcoholism
The Mind Research NetworkOTHER
26 Previous Clinical Trials
2,360 Total Patients Enrolled
8 Trials studying Alcoholism
926 Patients Enrolled for Alcoholism
Barbara McCrady, PhDPrincipal InvestigatorThe University of New Mexico

Media Library

Cognitive Behavior Therapy Clinical Trial Eligibility Overview. Trial Name: NCT03842670 — N/A
Alcoholism Research Study Groups: Cognitive-Behavior Therapy, Mindfulness Based Relapse Prevention
Alcoholism Clinical Trial 2023: Cognitive Behavior Therapy Highlights & Side Effects. Trial Name: NCT03842670 — N/A
Cognitive Behavior Therapy 2023 Treatment Timeline for Medical Study. Trial Name: NCT03842670 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there vacancies available in this research study?

"The clinicaltrials.gov website confirms that this trial is actively recruiting participants, with the original posting taking place on November 14th 2018 and last edited on February 7th 2022."

Answered by AI

Are any octogenarians being welcomed into this trial?

"According to the rules of eligibility, individuals aged 22 or above and no more than 85 may take part in this study."

Answered by AI

What type of individual is suitable to participate in this trial?

"This clinical trial seeks 140 individuals who consume alcohol in between the ages of 22 and 85. To qualify, candidates must register a Breath Alcohol Level (BAL) score of 0.00 at screening, identify as a heavy/binge or weekly drinker according to Babor et al.'s 2001 criteria,, demonstrate hazardous and harmful drinking behaviour through an AUDIT score > 8 for men and > 7 for women, be actively seeking help with their consumption habits, and be right handed."

Answered by AI

How many individuals are involved in the current research project?

"Affirmative. Found on clinicaltrials.gov, this medical trial is actively searching for individuals to join the study. First posted in November 14th 2018 and revised February 7th 2022, the research team seeks 140 volunteers from 2 different sites."

Answered by AI

Who else is applying?

What site did they apply to?
The University of New Mexico
What portion of applicants met pre-screening criteria?
Met criteria

Why did patients apply to this trial?

I had periods of cessation followed by humiliating and destructive relapses. I am willing to consider another approach. I would very much like to make it 15-months w/o a similar setback. Perhaps this therapy will be effective. In either case, I think I am probably a relevant data point.
PatientReceived no prior treatments
Recent research and studies
~10 spots leftby Sep 2024